Publicaciones en colaboración con investigadores/as de Universidade de Coimbra (44)

2024

  1. High prevalence of venous thrombotic events in Cushing’s syndrome: data from ERCUSYN and details in relation to surgery

    European Journal of Endocrinology, Vol. 190, Núm. 1, pp. 75-85

  2. Sexual dimorphism in the enamel-dentine junction (EDJ) of permanent canines of European modern humans

    American Journal of Biological Anthropology

2023

  1. Patient-reported burden and overall impact of dry eye disease across eight European countries: a cross-sectional web-based survey

    BMJ Open, Vol. 13, Núm. 3

  2. Real-world EGFR testing practices for non-small-cell lung cancer by thoracic pathology laboratories across Europe

    ESMO Open, Vol. 8, Núm. 5

2022

  1. ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19

    Scientific Data, Vol. 9, Núm. 1

  2. Imipenem-Relebactam Susceptibility in Enterobacterales Isolates Recovered from ICU Patients from Spain and Portugal (SUPERIOR and STEP Studies)

    Microbiology spectrum, Vol. 10, Núm. 5, pp. e0292722

  3. In vitro activity of imipenem/relebactam against Pseudomonas aeruginosa isolates recovered from ICU patients in Spain and Portugal (SUPERIOR and STEP studies)

    The Journal of antimicrobial chemotherapy, Vol. 77, Núm. 11, pp. 3163-3172

  4. Mapping genomic loci implicates genes and synaptic biology in schizophrenia

    Nature, Vol. 604, Núm. 7906, pp. 502-508

2021

  1. Bumetanide Oral Liquid Formulation for the Treatment of Children and Adolescents with Autism Spectrum Disorder: Design of Two Phase III Studies (SIGN Trials)

    Journal of Autism and Developmental Disorders, Vol. 51, Núm. 8, pp. 2959-2972

  2. Correction to: Bumetanide Oral Liquid Formulation for the Treatment of Children and Adolescents with Autism Spectrum Disorder: Design of Two Phase III Studies (SIGN Trials) (Journal of Autism and Developmental Disorders, (2021), 51, 8, (2959-2972), 10.1007/s10803-020-04709-8)

    Journal of Autism and Developmental Disorders

  3. Distinct epidemiology and resistance mechanisms affecting ceftolozane/tazobactam in Pseudomonas aeruginosa isolates recovered from ICU patients in Spain and Portugal depicted by WGS

    The Journal of antimicrobial chemotherapy, Vol. 76, Núm. 2, pp. 370-379

  4. Genetic variation in APOE, GRN, and TP53 are phenotype modifiers in frontotemporal dementia

    Neurobiology of Aging, Vol. 99, pp. 99.e15-99.e22

  5. Geometric Morphometrics of the human cervical vertebrae: sexual and population variations

    Journal of Anthropological Sciences, Vol. 99, pp. 97-116

  6. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  7. Heterogeneous contributions of change in population distribution of body mass index to change in obesity and underweight

    eLife, Vol. 10

  8. Management of anaphylaxis due to COVID-19 vaccines in the elderly

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 76, Núm. 10, pp. 2952-2964

  9. SARS-CoV-2 outbreak in immune-mediated inflammatory diseases: the Euro-COVIMID multicentre cross-sectional study

    The Lancet Rheumatology, Vol. 3, Núm. 7, pp. e481-e488

2020

  1. Microglial activation in the retina of a triple-transgenic alzheimer’s disease mouse model (3xTg-AD)

    International Journal of Molecular Sciences, Vol. 21, Núm. 3

  2. Role for ATXN1, ATXN2, and HTT intermediate repeats in frontotemporal dementia and Alzheimer's disease

    Neurobiology of Aging, Vol. 87, pp. 139.e1-139.e7

  3. Small Bowel Enteroscopy - A Joint Clinical Guideline from the Spanish and Portuguese Small Bowel Study Groups

    GE Portuguese Journal of Gastroenterology, Vol. 27, Núm. 5, pp. 324-335